Pharmacokinetics of oral noscapine
Authors:
- S A EckernäsSES A Eckernäs
- 1 September 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 39 (3) , 275-279
Abstract
The relative bioavailability in 20 healthy volunteers of 100 mg, 200 mg and 300 mg tablets of noscapine and 200 mg as a solution has been assessed in a four-way cross-over study, with repeated administration of the 200 mg dose to assess intraindividual variability. There was a disproportionate increase in the AUC of noscapine tablets, as a 3-fold increase in dose produced a 9-fold rise in AUC. This dose-dependency could mainly be attributed to saturable first-pass metabolism of the drug. Administration of noscapine as a solution resulted in a significantly higher maximal concentration at an earlier time-point and a higher AUC than the corresponding dose as tablets. Repeated administration of noscapine tablets and solution yielded higher AUC on the second dosing occasion. No cause for this carry-over effect was found, and the contribution of remaining noscapine was negligible. The terminal half-life of noscapine, which was independent of formulation or dose size was 4.5 h. Both inter- and intraindividual variability in noscapine kinetics were very high, e.g. 73% and 51% CV of the AUC for the 200 mg tablet.Keywords
This publication has 18 references indexed in Scilit:
- Determination of noscapine and its metabolites in plasma by coupled-column liquid chromatographyJournal of Chromatography A, 1988
- Estimation of binding parameters by kinetic data analysis: differentiation between one and two binding sitesEuropean Journal of Pharmacology, 1988
- Characterization of high-affinity binding sites for the antitussive [3H]noscapine in guinea pig brain tissueEuropean Journal of Pharmacology, 1988
- Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kineticsJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Pharmakokinetic properties of noscapineEuropean Journal of Clinical Pharmacology, 1982
- Metabolic fate of noscapine.; III. Further studies on identification and determination of the metabolitesXenobiotica, 1981
- Comparison of the antitussive effects of codeine phosphate 20 mg, dextromethorphan 30 mg and noscapine 30 mg using citric acid-induced cough in normal subjectsEuropean Journal of Clinical Pharmacology, 1979
- Metabolic fate of noscapine. II. Isolation and identification of novel metabolites produced by C—C bond cleavageXenobiotica, 1979
- Bioavailability calculations for drugs showing simultaneous first-order and capacity-limited elimination kineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- THE COUGH RESPONSE OF HEALTHY HUMAN SUBJECTS STIMULATED BY CITRIC ACID AEROSOLThe American Journal of the Medical Sciences, 1957